XRTX (XORTX Therapeutics Inc.) Short-Term Debt to Capital
XORTX Therapeutics Inc. (XRTX) is developing unique therapies for polycystic kidney disease by slowing tissue degradation through metabolic control. A well-established network of global raw material suppliers and strategic reserves ensure production stability. This price chart shows the metric at 0.00. Meanwhile, the business is implementing green chemistry principles, focusing specifically on energy efficiency and the safe disposal of chemical waste across its research centers.
Analytical breakdowns for XORTX Therapeutics Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital XORTX Therapeutics Inc.|XRTX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio XORTX Therapeutics|XRTX - Aggregate Debt Obligations|Debts to Book Capitalization XORTX Therapeutics Inc|XRTX - Long-Term Debt Volume|Company Short-Term Debt XORTX Therapeutics|Quick Liquidity xortx.com
- company profitability and valuation multiples indicators:
Fundamental valuation:XORTX
When assessing the long-term risks of XORTX Therapeutics Inc. (XRTX), an investor must analyze the ratio of current liabilities to equity, which measures the business's dependence on short-term debt financing; this is clearly reflected in the history of the short-term debt-to-equity level, allowing for a comparison of current liquidity against capital to ensure the development of drugs against kidney failure and the protection of future patent margins.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KALV: Short-Term Debt to Equity Ratio|SEPN (Septerna Pharma) - Short-Term Debt to Capital Ratio|Pieris Pharmaceuticals (PVLA) - Short-Term Debt to Equity|Current Liabilities to Capital savarapharma.com (SVRA)|Short-Term Debt to Equity Rigel Pharmaceuticals, Inc.|ANAB: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio ATXS (Astria Pharma)|Short-Term Loans to Capital Ratio ENGN|RAPT Therapeutics - Short-Term Debt to Equity Ratio|JBIO: Short-Term Debt to Capital Ratio|ACRS: Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital KYTX (Kyverna Therapeutics Inc.)|TLSA (Tiziana Life Sciences PLC) - Short-Term Debt to Equity Ratio|CABA: Short-Term Loans to Capital Ratio|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|THTX: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital AVTX|ELDN - Current Liabilities to Capital|Short-Term Debt to Equity Agenus Inc AGEN|Ratio of Short-Term Indebtedness to Capital CLYM|Zura Bio - Short-Term Debt to Capital|ATYR - Short-Term Debt to Capital|adagene.com (ADAG) - Short-Term Debt to Equity|Current Liabilities to Equity IMA (Ikena Oncology)|STTK (Shattuck Labs Inc) - Short-Term Debt to Capital|Current Liabilities to Capital Equillium Bio EQ|Short-Term Debt to Equity Ratio CNTB (Connect Biopharma)|Short-Term Debt to Capital immunic-therapeutics.com (IMUX)|Atara Bio - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio IFRX (InflaRx NV)|X4 Pharma - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Adicet Bio ACET|CELU: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio inmunebio.com|Short-Term Debt to Equity Barinthus Biotherapeutics plc|Kezar Life Sciences Inc. (KZR) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio SABS (SAB Biotherapeutics, Inc)|AKTX (Akari Therapeutics, Plc) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ENLV (Enlivex Therapeutics Ltd.)|Short-Term Debt to Capital Coefficient Q32 Bio Inc (QTTB)|GOVX - Short-Term Debt to Equity|EDSA (Edesa Biotech Inc) - Short-Term Debt to Capital Ratio|IBIO: Short-Term Debt to Capital|Short-Term Debt to Equity Ratio Carisma Therapeutics Inc.|Short-Term Debt to Equity Ratio XTLB|Bolt Bio (BOLT) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio HCWB (HCW Biologics Inc.)|aptevotherapeutics.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Equity AIM ImmunoTech Inc. AIM|Ratio of Short-Term Indebtedness to Capital ADTX|GRI: Short-Term Debt to Equity Ratio|reshapelifesciences.com - Short-Term Loans to Capital Ratio|REVB (Revelation Biosciences, Inc.) - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Ratio INDP|Short-Term Debt to Equity Scinai|CalciMedica Corp - Current Liabilities to Equity|Short-Term Debt to Capital AFMD|ALLK (allakos.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|ITOS - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital OCEA (Ocean Biomedical Corp)|TC Biopharm (TCBP) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio thirdharmonicbio.com